Replaces Prod. #: ALX-300-151
A cannabinoid CB1 and CB2 agonist equipotent with anandamide.
Product Details
| Alternative Name: | (Z,Z,Z)-5,8,11-Eicosatrienoic acid amide, N-(2-hydroxyethyl)- |
| |
| Formula: | C22H39NO2 |
| |
| MW: | 349.6 |
| |
| CAS: | 169232-04-6 |
| |
| Concentration: | 10 mg/ml |
| |
| Formulation: | Oil dissolved in ethanol. |
| |
| Purity: | ≥98% (TLC) |
| |
| Appearance: | Colorless liquid. |
| |
| Solubility: | Soluble in ethanol, DMSO (10mg/ml) or dimethyl formamide (30mg/ml). |
| |
| Shipping: | Dry Ice |
| |
| Long Term Storage: | -80°C |
| |
| Use/Stability: | Stable for at least 1 year after receipt when stored, as supplied, at -80°C. |
| |
| Handling: | Protect from light and oxygen. Keep under inert gas. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors: C.C. Felder, et al.; Mol. Pharmacol.
48, 443 (1995),
Abstract;
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors: J. Priller, et al.; Mol. Pharmacol.
48, 288 (1995),
Abstract;
